Prosidyan® is a medical device company focused on developing next generation bone graft substitute materials for orthopedic and spine applications.
Prosidyan®, founded in 2009, uses proprietary microscopic fibers of bioactive glass to develop a family of synthetic bioactive bone graft substitutes. Prosidyan®’s latest product, FIBERGRAFT® BG Matrix, consists of FIBERGRAFT® BG Morsels in a bioactive fiber collagen based carrier, providing the direct connectivity of fibers with exponentially increased surface area and optimized resorption rate. It can be used as a strip or a putty and has preclinical results equivalent to autograft in a challenging rabbit un-instrumented posterolateral spinal fusion model. FIBERGRAFT® technology represents the future of synthetic bioactive bone grafts.
For career opportunities: https://www.indeedjobs.com/prosidyan-inc/_hl/en_US